The DOI matches its Crossref record; 706 of the 706 references it cites were found in a registry or an index.
The role of serotonin in drug use and addiction
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 706
Ondansetron reduces the craving of biologically predisposed alcoholics
Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Zanca, N. A., & Velázquez, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1002-9 · Cited by 109
Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse
Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J., Onaivi, E. S., & Tyers, M. B. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90414-d · Cited by 109
Dhonnchadha, B. Á. N., Fox, R. G., Stutz, S. J., Rice, K. C., & Cunningham, K. A. (2009) · Behavioral Neuroscience · doi:10.1037/a0014592 · Cited by 109
Filip, M., & Cunningham, K. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045716 · Cited by 109
Animal Models and Brain Circuits in Drug Addiction
Kalivas, P. W., Peters, J., & Knackstedt, L. A. (2006) · Molecular Interventions · doi:10.1124/mi.6.6.7 · Cited by 108
Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats
Knapp, D. J., & Pohorecky, L. A. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90237-a · Cited by 107
Fluoxetine Alters the Effects of Intravenous Cocaine in Humans
WALSH, S. L., Preston, K. L., Sullivan, J. T., FROMME, R., & Bigelow, G. E. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00005 · Cited by 107
Filip, M., & Cunningham, K. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00741-9 · Cited by 106
A controlled trial of fluoxetine in crack cocaine dependence
Batki, S. L., Washburn, A. M., Delucchi, K., & Jones, R. T. (1996) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(96)01233-1 · Cited by 106
Serotonergic Attenuation of the Reinforcing and Neurochemical Effects of Cocaine in Squirrel Monkeys
Czoty, P. W., Ginsburg, B. C., & Howell, L. L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.831 · Cited by 105
Homberg, J. R., de Boer, S. F., Raasø, H. S., Olivier, J. D. A., Verheul, M., Ronken, E., Cools, A. R., Ellenbroek, B. A., Schoffelmeer, A. N. M., Vanderschuren, L. J. M. J., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1212-x · Cited by 104
Self-citationBurmeister, J. J., Lungren, E. M., Kirschner, K. F., & Neisewander, J. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300346 · Cited by 104
Moeller, F. G., Schmitz, J. M., Steinberg, J. L., Green, C. M., Reist, C., Lai, L. Y., Swann, A. C., & Grabowski, J. G. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990701313686 · Cited by 104
Johnson, B. A., Seneviratne, C., Wang, X.-Q., Ait‐Daoud, N., & Li, M. D. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12091163 · Cited by 104
Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
Callahan, P. M., & Cunningham, K. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10686-1 · Cited by 103
Bergman, J., Roof, R. A., Furman, C. A., Conroy, J., Mello, N. K., Sibley, D. R., & Skolnick, P. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000661 · Cited by 103
Bankson, M. G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00345-1 · Cited by 102
Fletcher, P. J., Rizos, Z., Noble, K., & Higgins, G. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.025 · Cited by 102
Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists
Castanon, N., Scearce-Levie, K. A., Lucas, J. J., Rocha, B., & Hen, R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00389-0 · Cited by 101
Enoch, M.-A., Gorodetsky, E., Hodgkinson, C. A., Roy, A., & Goldman, D. A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.94 · Cited by 101
From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists
Higgins, G. A., Sellers, E. M., & Fletcher, P. J. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.001 · Cited by 100
Intravenous self-administration of cocaine and norcocaine by dogs
Risner, M. E., & Jones, B. E. (1980) · Psychopharmacology · doi:10.1007/bf00433258 · Cited by 99
Singer, S., Rossi, S., Verzosa, S., Hashim, A. T., Lonow, R., Cooper, T. B., Sershen, H. W., & Lajtha, Á. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000035814.45494.15 · Cited by 98
Serotonergic mechanisms of cocaine effects in humans
Aronson, S., Black, J. E., McDougle, C. J., Scanley, B. E., Heninger, G. R., Price, L. H., Jatlow, P. L., & Kosten, T. R. (1995) · Psychopharmacology · doi:10.1007/bf02246159 · Cited by 98
Cunningham, K. A., Anastasio, N. C., Fox, R. G., Stutz, S. J., Bubar, M. J., Swinford-Jackson, S. E., Watson, C. S., Gilbertson, S. R., Rice, K. C., Rosenzweig-Lipson, S. J., et al. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300072u · Cited by 98
Tao, R., & Auerbach, S. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038133 · Cited by 98
5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning
Carboni, E., Acquas, E., Leone, P., Perezzani, L., & Chiara, G. D. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90710-8 · Cited by 98
Cocaine modulation of central monoaminergic neurotransmission
Pitts, D. K., & Marwah, J. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90147-x · Cited by 98
Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats
Jackson, D. M., Johansson, C., Lindgren, L.-M., & Bengtsson, A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90554-1 · Cited by 97
Leccese, A. P., & Lyness, W. H. (1984) · Brain Research · doi:10.1016/0006-8993(84)90223-3 · Cited by 97
Sites of action of ondansetron to inhibit withdrawal from drugs of abuse
Costall, B., Jones, B., Kelly, M. E., Naylor, R. J., Onaivi, E. S., & Tyers, M. B. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90132-2 · Cited by 97
An investigation of the role of 5-HT2C receptors in modifying ethanol self-administration behaviour
Tomkins, D. M., Joharchi, N., Tampakeras, M., Martin, J. R., Wichmann, J., & Higgins, G. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00710-9 · Cited by 97
Baker, D. L., Tran-Nguyen, L. T. L., Fuchs, R. A., & Neisewander, J. L. (2001) · Psychopharmacology · doi:10.1007/s002130000676 · Cited by 97
Yang, K. S., Galadari, S., Isaev, D. S., Petroianu, G. A., Shippenberg, T. S., & Öz, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162594 · Cited by 97
Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation
Rutter, J. J., Gundlah, C., & Auerbach, S. B. (1995) · Synapse · doi:10.1002/syn.890200306 · Cited by 96
Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice
Doly, S., Bertran‐Gonzalez, J., Callebert, J., Bruneau, A., Banas, S. M., Belmer, A., Boutourlinsky, K., Hervé, D., Launay, J., & Maroteaux, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007952 · Cited by 96
Chen, C., & Anthony, J. C. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1624-6 · Cited by 96
Spring, B. J., Wurtman, J. J., Gleason, R. E., Wurtman, R. J., & al, E. (1991) · Health Psychology · doi:10.1037//0278-6133.10.3.216 · Cited by 96
Monoamine Oxidase Inhibitors Allow Locomotor and Rewarding Responses to Nicotine
Villégier, A., Salomon, L., Granon, S., Changeux, J., Belluzzi, J. D., Leslie, F. M., & Tassin, J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300987 · Cited by 95
Fletcher, P. J., Korth, K. M., Robinson, S. K., & Baker, G. B. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1104-4 · Cited by 95
Filip, M., Alenina, N., Bader, M., & Przegaliński, E. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00214.x · Cited by 94
Frantz, K. J., Hansson, K. J., Stouffer, D. G., & Parsons, L. H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00165-4 · Cited by 94
Functional methamphetamine use: The insider's perspective
Lende, D. H., Leonard, T., Sterk, C. E., & Elifson, K. W. (2007) · Addiction Research & Theory · doi:10.1080/16066350701284552 · Cited by 94
Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT 1B receptor
Scearce-Levie, K. A., Viswanathan, S. S., & Hen, R. (1999) · Psychopharmacology · doi:10.1007/s002130050819 · Cited by 93
Fletcher, P. J., Sinyard, J., & Higgins, G. A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0453-9 · Cited by 92
Callaway, C. W., Rempel-Clower, N., Ry, P., & Geyer, M. A. (1992) · PubMed · Cited by 92
Trigo, J. M., Renoir, T., Lanfumey, L., Hamon, M., Lesch, K., Robledo, P., & Maldonado, R. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.005 · Cited by 91
Schmidt, C. J. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90782-5 · Cited by 91
Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons
Schmidt, C. J., & Taylor, V. L. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90154-9 · Cited by 91
Laucht, M., Treutlein, J., Schmid, B., Blomeyer, D., Becker, K., Buchmann, A. F., Schmidt, M. H., Esser, G., Jennen-Steinmetz, C., Rietschel, M., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.010 · Cited by 90
Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment.
NIAURA, R. S., Spring, B. J., Borrelli, B., Hedeker, D., Goldstein, M. G., Keuthen, N. J., DePue, J. D., Kristeller, J. L., Ockene, J., Prochazka, A. V., et al. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.4.887 · Cited by 90
A Randomized Trial of Sertraline as a Cessation Aid for Smokers With a History of Major Depression
Covey, L. S., Glassman, A. H., Stetner, F., Rivelli, S. K., & Stage, K. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1731 · Cited by 90
Tryptophan depletion and attenuation of cue-induced craving for cocaine
Satel, S. L., Krystal, J. H., Delgado, P. L., Kosten, T. R., & Charney, D. S. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.778 · Cited by 90
Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use
Erritzøe, D., Frøkjær, V. G., Haugbøl, S., Marner, L., Svarer, C., Holst, K. K., Baaré, W. F. C., Rasmussen, P. M., Madsen, J., Paulson, O. B., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.050 · Cited by 89
Li, T., Liu, X., Zhao, J., Hu, X., Ball, D. M., Loh, E., Sham, P. C., & Collier, D. A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10200 · Cited by 88
Ethanol Inhibits Clearance of Brain Serotonin by a Serotonin Transporter-Independent Mechanism
Daws, L. C., Montañez, S., Munn, J. L., Owens, W. A., Baganz, N. L., Boyce‐Rustay, J. M., Millstein, R. A., Wiedholz, L. M., Murphy, D. L., & Holmes, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4050-05.2006 · Cited by 88
Miczek, K. A., & Yoshimura, H. (1982) · Psychopharmacology · doi:10.1007/bf00435272 · Cited by 88
Neisewander, J. L., & Acosta, J. I. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f1c94b · Cited by 88
Pum, M. E., Carey, R. J., Huston, J. P., & Müller, C. P. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0791-2 · Cited by 88
Self-citationEthanol‐Related Behaviors in Serotonin Transporter Knockout Mice
Boyce‐Rustay, J. M., Wiedholz, L. M., Millstein, R. A., Carroll, J. C., Murphy, D. L., Daws, L. C., & Holmes, A. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00241.x · Cited by 88
Serotonin‐3 Receptors in the Actions of Alcohol, Alcohol Reinforcement, and Alcoholism
McBride, W. J., Lovinger, D. M., Machu, T. K., Thielen, R. J., Rodd, Z. A., Murphy, J. M., Roache, J. D., & Johnson, B. A. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000113419.99915.da · Cited by 88
Intravenous cocaine-induced place preference: attenuation by haloperidol
Spyraki, C., Nomikos, G. G., & Varonos, D. D. (1987) · Behavioural Brain Research · doi:10.1016/0166-4328(87)90016-7 · Cited by 87
Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning
Higgins, G. A., Joharchi, N., Nguyen, P., & Sellers, E. M. (1992) · Psychopharmacology · doi:10.1007/bf02245411 · Cited by 87
Karg, K., Burmeister, M., Shedden, K., & Sen, S. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.189 · Cited by 87
Pei, Q., Zetterström, T., Leslie, R. A., & Grahame-Smith, D. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90410-j · Cited by 86
Baumann, M. H., & Rothman, R. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00123-1 · Cited by 86
Tao, R., & Auerbach, S. B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020517.x · Cited by 85
Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms
Stolerman, I. P., Pratt, J. A., Garcha, H. S., et al. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90021-7 · Cited by 85
Fadda, P., Scherma, M., Fresu, A., Collu, M., & Fratta, W. (2005) · Synapse · doi:10.1002/syn.20122 · Cited by 85
Lorcaserin, a 5-HT2C Agonist, Decreases Nicotine Self-Administration in Female Rats
Levin, E. D., Johnson, J. E., Slade, S. K., Wells, C., Cauley, M. C., Petro, A. E., & Rose, J. E. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183525 · Cited by 85
The discriminative stimulus effects of cocaine in pigeons.
Johanson, C. E., & Barrett, J. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39359-6 · Cited by 84
Garduño, J., Galindo-Charles, L., Jiménez-Rodríguez, J., Galarraga, E., Tapia, D., Mihailescu, S., & Hernandez-Lopez, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0941-12.2012 · Cited by 83
Yoshimoto, K., Ueda, S., Kato, B., Takeuchi, Y., Kawai, Y., Noritake, K., & Yasuhara, M. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00037-1 · Cited by 83
Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine
Budygin, E. A., Brodie, M. S., Sotnikova, T. D., Mateo, Y., John, C. E., Cyr, M., Gainetdinov, R. R., & Jones, S. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401418101 · Cited by 83
Gerra, G., Garofano, L., Zaimovic, A., Moi, G., Branchi, B., Bussandri, M., Brambilla, F., & Donnini, C. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30173 · Cited by 83
Pockros, L. A., Pentkowski, N. S., Swinford-Jackson, S. E., & Neisewander, J. L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2071-9 · Cited by 83
McGregor, A., Lacosta, S., & Roberts, D. C. S. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90181-r · Cited by 82
Egashira, N., Mishima, K., Katsurabayashi, S., Yoshitake, T., Matsumoto, Y., Ishida, J., Yamaguchi, M., Iwasaki, K., & Fujiwara, M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01755-7 · Cited by 82
Besson, M., Pelloux, Y., Dilleen, R., Theobald, D. E., Lyon, A., Belin-Rauscent, A., Robbins, T. W., Dalley, J. W., Everitt, B. J., & Belin, D. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.95 · Cited by 81
Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens
Andrews, C. M., & Lucki, I. (2001) · Psychopharmacology · doi:10.1007/s002130100704 · Cited by 81
Effects of Combined Fluoxetine and Counseling in the Outpatient Treatment of Cocaine Abusers
Covi, L., Hess, J. M., Kreiter, N. A., & Haertzen, C. A. (1995) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999509002701 · Cited by 81
Extracellular Dopamine and Serotonin After Ethanol Monitored With 5-Minute Microdialysis
Yan, Q. (1999) · Alcohol · doi:10.1016/s0741-8329(99)00006-3 · Cited by 79
Tomkins, D. M., Sellers, E. M., & Fletcher, P. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90065-5 · Cited by 79
Carlsson, M. L., Martin, P., Nilsson, M., Sorensen, S. M., Carlsson, A., Waters, N., & Waters, N. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050144 · Cited by 78
Pentkowski, N. S., Boynton, F. D. D., Weber, S. M., Pockros, L. A., Teer, A. P., Hamilton, E. C., Thiel, K. J., & Neisewander, J. L. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.72 · Cited by 78
Ecology and neurobiology of toxin avoidance and the paradox of drug reward
Hagen, E. H., Sullivan, R. J., Schmidt, R., Morris, G., Kempter, R., & Hammerstein, P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.077 · Cited by 78
Faleiro, L. J., Jones, S., & Kauer, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300495 · Cited by 77
Involvement of the serotonergic system in ethanol intake in the rat
Svensson, L., Fahlke, C., Hȧrd, E., & Engel, J. A. (1993) · Alcohol · doi:10.1016/0741-8329(93)90039-q · Cited by 77
Fluoxetine attenuates alcohol intake and desire to drink
Naranjo, C. A., Poulos, C. X., Bremner, K. E., & Lanctôt, K. L. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00004 · Cited by 77
Anastasio, N. C., Stutz, S. J., Fox, R. G., Sears, R. M., Emeson, R. B., Dileone, R., O’Neil, R. T., Fink, L. H. L., Li, D., Green, T. A., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.199 · Cited by 76
Sabol, K. E., & Seiden, L. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00720-3 · Cited by 76
Tao, R., Ma, Z., & Auerbach, S. B. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37608-6 · Cited by 75
Burbassi, S., & Cervo, L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0916-7 · Cited by 75
Harris, G. C. M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00184-6 · Cited by 75
Müller, C. P., & Huston, J. P. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.12.003 · Cited by 74
Self-citationCarey, R. J., DePalma, G., Damianopoulos, E. N., M�ller, C., & Huston, J. P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1917-4 · Cited by 74
Self-citationZhou, Q., Verdoorn, T. A., & Lovinger, D. M. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.335bt.x · Cited by 74
Lozano, R. P., Farré, M., Yubero‐Lahoz, S., O’Mathúna, B., Torrens, M., Mustata, C., Pérez‐Mañá, C., Langohr, K., Cuyàs, E., Carbó, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047599 · Cited by 74
Effects of fluoxetine and d-fenfluramine on cocaine-seeking behavior in rats
Burmeister, J. J., Lungren, E. M., & Neisewander, J. L. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1307-8 · Cited by 73
Rodd, Z. A., Bell, R. L., Kuc, K. A., Zhang, Y., Murphy, J. M., & McBride, W. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075952 · Cited by 72
Zhang, X., Lee, T. H., Davidson, C., Lazarus, C., Wetsel, W. C., & Ellinwood, E. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301101 · Cited by 72
Adams, W. K., Kusljic, S., & van den Buuse, M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.035 · Cited by 72
King, G., Xiong, Z. Z., Douglas, S., & Ellinwood, E. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00926-7 · Cited by 72
Serotonin 1B Receptor Imaging in Alcohol Dependence
Hu, J., Henry, S. E., Gallezot, J., Ropchan, J. R., Neumaier, J. F., Potenza, M. N., Sinha, R., Krystal, J. H., Huang, Y. H., Ding, Y., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.028 · Cited by 71
Munzar, P., Baumann, M. H., Shoaib, M. C., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050836 · Cited by 71
Ramos, M., Goñi‐Allo, B., & Aguirre, N. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300735 · Cited by 71
The nucleus accumbens 5-HTR4-CART pathway ties anorexia to hyperactivity
Jean, A., Laurent, L., Bockaert, J., Charnay, Y., Dusticier, N., Nieoullon, A., Barrot, M., Neve, R. L., & Compan, V. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.131 · Cited by 70
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal
Zaniewska, M., McCreary, A. C., Wydra, K., & Filip, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.006 · Cited by 70
Tryptophan hydroxylase gene variant and smoking behavior
Lerman, C. E., Caporaso, N. E., Bush, A., Zheng, Y., Audrain, J. E., Main, D., & Shields, P. G. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1476 · Cited by 70
Fletcher, P. J., Rizos, Z., Noble, K., Soko, A. D., Silenieks, L. B., Lê, A. D., & Higgins, G. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.023 · Cited by 70
Garza, R. D. L., & Cunningham, K. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35331-5 · Cited by 70
Topiramate selectively attenuates nicotine-induced increases in monoamine release
Schiffer, W. K., Gerasimov, M. R., Marsteller, D. A., Geiger, J., Barnett, C., Alexoff, D. L., & Dewey, S. L. (2001) · Synapse · doi:10.1002/syn.10000 · Cited by 69
Carpenter, K. M., Brooks, A. C., Vosburg, S. K., & Nunes, E. V. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.015 · Cited by 69
Auclair, A. L., Cathala, A., Sarrazin, F., Depoortère, R., Piazza, P. V., Newman‐Tancredi, A., & Spampinato, U. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06848.x · Cited by 69
A microdialysis study of the medial prefrontal cortex of adolescent and adult rats
Staiti, A. M., Morgane, P. J., Galler, J. R., Grivetti, J. Y., Bass, D. C., & Mokler, D. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.005 · Cited by 68
Discriminative Stimulus Properties of Cocaine: Enhancement by Monoamine Reuptake Blockers
Kleven, M. S., & Koek, W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37310-0 · Cited by 67
Herin, D. V., Liu, S., Ullrich, T., Rice, K. C., & Cunningham, K. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2030-4 · Cited by 67
Correlation of behavioral and neurochemical effects of acute administration of cocaine in rats
Pradhan, S., Roy, S. N., & Pradhan, S. N. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90626-4 · Cited by 66
αCaMKII Autophosphorylation Controls the Establishment of Alcohol Drinking Behavior
Easton, A. C., Lucchesi, W., Lourdusamy, A., Lenz, B., Solati, J., Golub, Y., Lewczuk, P., Fernandes, C., Desrivières, S., Dawirs, R. R., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.60 · Cited by 66
Self-citationLane, J. D., Pickering, C. L., Hooper, M. L., Fagan, K., Tyers, M. B., & Emmett‐Oglesby, M. W. (1992) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(92)90020-d · Cited by 66
Sensitization of Amphetamine-Induced Stereotyped Behaviors During the Acute Response
Kuczenski, R. T., & Segal, D. S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38009-7 · Cited by 65
Cao, J. P., LaRocque, E., & Li, D. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32128 · Cited by 65
Göktürk, C., Schultze, S., Nilsson, K. W., von Knorring, L., Oreland, L., & Hallman, J. (2008) · Archives of Women s Mental Health · doi:10.1007/s00737-008-0033-6 · Cited by 65
Sano, K., Mishima, K., Koushi, E., Orito, K., Egashira, N., Irie, K., Takasaki, K., Katsurabayashi, S., Iwasaki, K., Uchida, N., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.026 · Cited by 65
Bambico, F. R., Hattan, P. R., Garant, J.-P., & Gobbi, G. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.006 · Cited by 65
Kankaanpää, A., Meririnne, E., & Seppαlä, T. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0939-4 · Cited by 65
Manvich, D. F., Kimmel, H. L., & Howell, L. L. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.186981 · Cited by 65
Callaway, C. W., & Geyer, M. A. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10342-x · Cited by 64
Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals.
Johnson, B., Ait-Daoud, N., Ma, J.-N. Z., & Wang, Y. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000095635.46911.5d · Cited by 64
Sizemore, G. M., Co, C., & Smith, J. E. (2000) · Psychopharmacology · doi:10.1007/s002130000456 · Cited by 64
Ait‐Daoud, N., Seneviratne, C., Smith, J. B., Roache, J. D., Dawes, M. A., Liu, L., Wang, X., & Johnson, B. A. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00006 · Cited by 64
Müller, C. P., Carey, R. J., Silva, M. A. D. S., Jocham, G., & Huston, J. P. (2002) · Synapse · doi:10.1002/syn.10083 · Cited by 64
Self-citationDietary tryptophan supplements attenuate amphetamine self-administration in the rat
Smith, F. L., Yu, D. S. L., Smith, D. G., Leccese, A. P., & Lyness, W. H. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90397-7 · Cited by 64
Zayara, A. E., McIver, G., Valdivia, P. N., Lominac, K. D., McCreary, A. C., & Szumlinski, K. K. (2011) · Psychopharmacology · doi:10.1007/s00213-010-1996-3 · Cited by 64
Nicotine regulates 5‐HT1A receptor gene expression in the cerebral cortex and dorsal hippocampus
Kenny, P. J., File, S. E., & Rattray, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01501.x · Cited by 63
Association of the HTR2A gene with alcohol and heroin abuse
Cao, J. P., Liu, X., Han, S., Zhang, H., Liu, Z. Z., & Li, D. (2013) · Human Genetics · doi:10.1007/s00439-013-1388-y · Cited by 63
Bubar, M. J., McMahon, L. R., Deurwaerdère, P. D., Spampinato, U., & Cunningham, K. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00381-7 · Cited by 63
Braida, D., Iosuè, S., Pegorini, S., & Sala, M. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.07.009 · Cited by 62
Episodic Memories and Their Relevance for Psychoactive Drug Use and Addiction
Müller, C. P. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00034 · Cited by 62
Self-citationBarot, S. K., Ferguson, S. M., & Neumaier, J. F. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05568.x · Cited by 61
Ago, Y., Nakamura, S., Uda, M., Kajii, Y., ABE, M., BABA, A., & MATSUDA, T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.001 · Cited by 61
tski, E. P., & Filip, M. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199712000-00004 · Cited by 61
Yoshimoto, K., & Komura, S. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90575-2 · Cited by 61
Rasmussen, K., Calligaro, D. O., Czachura, J. F., Dreshfield, L. J., Evans, D. C., Hemrick-Luecke, S. K., Kallman, M. J., Kendrick, W. T., Leander, J. D., Nelson, D. L. G., et al. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39123-2 · Cited by 61
5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat
Maurel, S., Vry, J. D., & Schreiber, R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00125-9 · Cited by 61
Marihuana. The First Twelve Thousand Years.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-3-397_2 · Cited by 61
Cigler, T., LaForge, K. S., McHugh, P. F., Kapadia, S. U., Leal, S. M., & Kreek, M. J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1473 · Cited by 60
Ivanova, S. А., & Greenshaw, A. J. (1997) · Psychopharmacology · doi:10.1007/s002130050441 · Cited by 60
Multi-Cultural Association of the Serotonin Transporter Gene (SLC6A4) with Substance Use Disorder
Cao, J. P., Hudziak, J. J., & Li, D. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.73 · Cited by 60
Effects of Cocaine and MDMA Self-Administration on Serotonin Transporter Availability in Monkeys
Banks, M. L., Czoty, P. W., Gage, H. D., Bounds, M. C., Garg, P., Garg, S., & Nader, M. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301420 · Cited by 60
Stimulation of 5-HT1B receptors decreases cocaine- and sucrose-seeking behavior
Acosta, J. I., Boynton, F. A., Kirschner, K. F., & Neisewander, J. L. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.12.001 · Cited by 60
Hagino, Y., Takamatsu, Y., Yamamoto, H., Iwamura, T., Murphy, D. L., Uhl, G. R., Sora, I., & Ikeda, K. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017254 · Cited by 60
Proudnikov, D., LaForge, K. S., Hofflich, H., Levenstien, M. A., Gordon, D., Barral, S., Ott, J., & Kreek, M. J. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000182782.87932.d6 · Cited by 60
Seneviratne, C., Huang, W., Ait‐Daoud, N., Li, M. D., & Johnson, B. A. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00837.x · Cited by 60
David, S. P., Munafo, M. R., Murphy, M., Walton, R. T., & Johnstone, E. C. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200601078566 · Cited by 60
ALCOHOL INTAKE AFTER SEROTONIN TRANSPORTER INACTIVATION IN MICE
Kelaï, S. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg095 · Cited by 59
Tomkins, D. M., Higgins, G. A., & Sellers, E. M. (1994) · Psychopharmacology · doi:10.1007/bf02244769 · Cited by 59
Series, H. G., Cowen, P. J., & Sharp, T. (1994) · Psychopharmacology · doi:10.1007/bf02247485 · Cited by 59
Olausson, P., Engel, J. A., & Söderpalm, B. (1999) · Psychopharmacology · doi:10.1007/s002130050869 · Cited by 59
Serotonin2Creceptors in the nucleus accumbens are involved in enhanced alcohol‐drinking behavior
Yoshimoto, K., Watanabe, Y., Tanaka, M., & Kimura, M. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08037.x · Cited by 58
Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation
Spring, B. J., Wurtman, J. J., Wurtman, R. J., El-Khoury, A. E., Goldberg, H., Mcdermott, J., & Pingitore, R. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1181 · Cited by 58
5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism
Svingos, A. L., & HITZEMANN, R. J. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90420-k · Cited by 58
A serotonin transporter polymorphism (5-HTTLPR) predicts the development of adolescent alcohol use
van der Zwaluw, C. S., Engels, R. C. M. E., Vermulst, A. A., Rose, R. J., Verkes, R. J., Buitelaar, J. K., Franke, B., & Scholte, R. H. J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.06.001 · Cited by 58
Electrophysiological effects of cocaine on central monoaminergic neurons
Pitts, D. K., & Marwah, J. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90520-0 · Cited by 57
Waters, K. A., Stean, T. O., Hammond, B., Virley, D. J., Upton, N., Kew, J. N. C., & Hussain, I. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.009 · Cited by 57
Jakubczyk, A., Wrzosek, M., Łukaszkiewicz, J., Sadowska-Mazuryk, J., Matsumoto, H., Śliwerska, E., Glass, J. M., Burmeister, M., Brower, K. J., & Wojnar, M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.001 · Cited by 57
Serotonin depletion attenuates cocaine-seeking behavior in rats
Tran-Nguyen, L. T. L., Baker, D. L., Grote, K. A., Solano, J. M., & Neisewander, J. L. (1999) · Psychopharmacology · doi:10.1007/s002130051088 · Cited by 57
Bleich, S., Bönsch, D., Rauh, J., Bayerlein, K., Fiszer, R., Frieling, H., & Hillemacher, T. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm068 · Cited by 57
Ahtee, L., Attila, L. M. J., Carlson, K. R., & Haikala, H. M. (1988) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-10047-7_44 · Cited by 57
Neal‐Beliveau, B. S., & Sparber, S. B. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38789-6 · Cited by 57
Kuroki, T., Ichikawa, J., Dai, J., & Meltzer, H. Y. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01111-0 · Cited by 56
Munzar, P., Laufert, M. D., Kutkat, S. W., Nováková, J., & Goldberg, S. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35094-3 · Cited by 56
Schenk, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00377-4 · Cited by 55
Cervo, L., Rozio, M. G., Ekalle-Soppo, C. B., Carnovali, F., Santangelo, E., & SAMANIN, R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1145-8 · Cited by 55
Nomikos, G. G., & Spyraki, C. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90110-4 · Cited by 55
Association of the serotonin transporter gene polymorphism with Korean male alcoholics
Kweon, Y. S., Lee, H., Lee, C. T., Lee, K., & Pae, C. U. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.10.005 · Cited by 55
Tran-Nguyen, L. T. L., Bellew, J., Grote, K. A., & Neisewander, J. L. (2001) · Psychopharmacology · doi:10.1007/s002130100822 · Cited by 55
McCann, U. D., & Ricaurte, G. A. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199306000-00011 · Cited by 55
Available, N. A. N., & Available, N. A. N. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000381 · Cited by 55
Acquisition of MDMA self‐administration: pharmacokinetic factors and MDMA ‐induced serotonin release
Bradbury, S., Bird, J., Colussi‐Mas, J., Mueller, M., Ricaurte, G. A., & Schenk, S. (2013) · Addiction Biology · doi:10.1111/adb.12069 · Cited by 54
Olausson, P., Åkesson, P., Engel, J. A., & Söderpalm, B. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00939-6 · Cited by 54
TPH2 and TPH1: Association of Variants and Interactions with Heroin Addiction
Nielsen, D. A., Barral, S., Proudnikov, D., Kellogg, S. H., Ho, A., Ott, J., & Kreek, M. J. (2008) · Behavior Genetics · doi:10.1007/s10519-007-9187-7 · Cited by 54
Weinstein, A. M., Miller, H., Bluvstein, I., Rapoport, E., Schreiber, S., Bar-Hamburger, R., & Bloch, M. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.819362 · Cited by 53
Rossi, S., Singer, S., Shearman, E., Sershen, H., & Lajtha, A. (2005) · Neurochemical Research · doi:10.1007/s11064-005-2689-x · Cited by 53
Effect of 5-HT1B Receptor Ligands on Self-administration of Ethanol in an Operant Procedure in Rats
Tomkins, D. M., & O‘Neill, M. F. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00232-x · Cited by 53
Fletcher, P. J., Azampanah, A., & Korth, K. M. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00717-1 · Cited by 53
Kusljic, S., Copolov, D., & van den Buuse, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300277 · Cited by 53
Winstanley, E. L., Bigelow, G. E., Silverman, K., Johnson, R. E., & Strain, E. C. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.11.010 · Cited by 53
Oakly, A., Brox, B. W., Schenk, S., & Ellenbroek, B. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.75 · Cited by 53
Pentkowski, N. S., Acosta, J. I., Browning, J. R., Hamilton, E. C., & Neisewander, J. L. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00162.x · Cited by 52
Involvement of Serotonin in the Modulation of Cocaine-Induced Locomotor Activity in the Rat
Herges, S., & TAYLOR, D. A. H. B. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00473-5 · Cited by 52
Corrigall, W. A., & Coen, K. M. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90457-x · Cited by 52
Gately, P. F., Poon, S. L., Segal, D. S., & Geyer, M. A. (1985) · Psychopharmacology · doi:10.1007/bf00432502 · Cited by 52
Ferguson, S. M., Mitchell, E. S., & Neumaier, J. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.018 · Cited by 52
Cocaine interaction withc entral monoaminergic systems: electrophysiological approaches
Lakoski, J. M., & Cunningham, K. A. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90034-x · Cited by 52
Higgins, G. A., Nguyen, P., Joharchi, N., & Sellers, E. M. (1991) · Psychopharmacology · doi:10.1007/bf02244425 · Cited by 52
Pinto, E., Reggers, J., Gorwood, P. A. P. M., Boni, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn015 · Cited by 52
Locally Administered Low Nicotine-Induced Neurotransmitter Changes in Areas of Cognitive Function
Shearman, E., Rossi, S., Sershen, H., Hashim, A., & Lajtha, A. (2005) · Neurochemical Research · doi:10.1007/s11064-005-7132-9 · Cited by 51
Higgins, G. A., Wang, Y., Corrigall, W. A., & Sellers, E. M. (1994) · Psychopharmacology · doi:10.1007/bf02244992 · Cited by 51
Neisewander, J. L., Cheung, T. H. C., & Pentkowski, N. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.014 · Cited by 51
Research works printed but not linked: 97
- Abdollahian, 2006, Study of the efficacy of fluoxetine and clomipramine in the treatment of premature ejaculation after opioid detoxification, Am J Addict, 15, 100, 10.1080/10550490500419151 · doi:10.1080/10550490500419151
- Acquas, 1988, 5-HT3 receptors antagonists block morphine- and nicotine- but not amphetamine-induced place-preference conditioning, Pharmacol Res Commun, 20, 1113, 10.1016/S0031-6989(88)80752-5 · doi:10.1016/s0031-6989(88)80752-5
- Adell, 1995, Selective destruction of midbrain raphe nuclei by 5,7-DHT: is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats?, Brain Res, 693, 70, 10.1016/0006-8993(95)00701-Q · doi:10.1016/0006-8993(95)00701-q
- Ali, 1996, 8-OH-DPAT enhances the expression of cocaine-induced place preference, Br J Pharmacol Suppl, 119, 207P
- Baker, 1993, The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds, Behav Pharmacol, 4, 69, 10.1097/00008877-199302000-00008 · doi:10.1097/00008877-199302000-00008
- Baker, 1997, Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA), Pharmacol Biochem Behav, 58, 505, 10.1016/S0091-3057(97)00287-6 · doi:10.1016/s0091-3057(97)00287-6
- Bare, 1998, Development of rapid tolerance to ethanol-stimulated serotonin release in the ventral hippocampus, Alcohol Clin Exp Res, 22, 1272, 10.1111/j.1530-0277.1998.tb03908.x · doi:10.1111/j.1530-0277.1998.tb03908.x
- Berthold, 1989, 5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice, Eur J Pharmacol, 162, 19, 10.1016/0014-2999(89)90599-2 · doi:10.1016/0014-2999(89)90599-2
- Bilsky, 1991, MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference, Pharmacol Biochem Behav, 39, 509, 10.1016/0091-3057(91)90217-P · doi:10.1016/0091-3057(91)90217-p
- Bisaga, 1993, The effect of drugs interacting with serotonergic 5-HT3 and 5-HT4 receptors on morphine place conditioning, Pol J Pharmacol, 45, 513
- Bronsert, 2001, Amphetamine-induced locomotor activation in 5-HT(1B) knockout mice: effects of injection route on acute and sensitized responses, Behav Pharmacol, 12, 549, 10.1097/00008877-200111000-00017 · doi:10.1097/00008877-200111000-00017
- Burnett, 2012, The effects of chronic ethanol self-administration on hippocampal serotonin transporter density in monkeys, Front Psychiatry, 3, 38, 10.3389/fpsyt.2012.00038 · doi:10.3389/fpsyt.2012.00038
- Callahan, 1997, Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists, Neuropharmacology, 36, 373, 10.1016/S0028-3908(97)00010-5 · doi:10.1016/s0028-3908(97)00010-5
- Carey, 2002, 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms, Behav Brain Res, 132, 37, 10.1016/S0166-4328(01)00383-7 · doi:10.1016/s0166-4328(01)00383-7
- Carey, 2005, Pharmacological inhibition of DA- and 5-HT activity blocks spontaneous and cocaine-activated behavior: reversal by chronic cocaine treatment, Brain Research, 1047, 194, 10.1016/j.brainres.2005.04.042 · DOI
- Cervo, 1996, 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats, Pharmacol Biochem Behav, 55, 33, 10.1016/0091-3057(96)00046-9 · doi:10.1016/0091-3057(96)00046-9
- Ciccocioppo, 1997, Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats, Psychopharmacology (Berl), 134, 55, 10.1007/s002130050425 · doi:10.1007/s002130050425
- Conductier, 2005, 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221, Neuropsychopharmacology, 30, 1056, 10.1038/sj.npp.1300662 · doi:10.1038/sj.npp.1300662
- De La Garza, 1996, Detailed investigations of 5-HT3 compounds in a drug discrimination model, Pharmacol Biochem Behav, 54, 533, 10.1016/0091-3057(95)02207-4 · doi:10.1016/0091-3057(95)02207-4
- De La Garza, 1998, The discriminative stimulus properties of cocaine: effects of microinfusion of cocaine, a 5-HT1A agonist or antagonist, into the ventral tegmental area, Psychopharmacology (Berl), 137, 1, 10.1007/s002130050586 · doi:10.1007/s002130050586
- Devoto, 1998, Serotonin is reduced in the frontal cortex of Sardinian ethanol-preferring rats, Alcohol Alcohol, 33, 226, 10.1093/oxfordjournals.alcalc.a008386 · DOI
- Dukat, 2007, The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats, Pharmacol Biochem Behav, 87, 203, 10.1016/j.pbb.2007.03.008 · doi:10.1016/j.pbb.2007.03.008
- El-Kadi, 1995, The role of 5-Ht in the expression of morphine-withdrawal in mice, Life Sci, 57, 511, 10.1016/0024-3205(95)00284-D · doi:10.1016/0024-3205(95)00284-d
- Filip, 2001, Serotonin1B receptor ligands in the nucleus accumbens shell do not affect the discriminative stimulus effects of amphetamine in rats, Pol J Pharmacol, 53, 449
- Filip, 2002, Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats, Naunyn Schmiedebergs Arch Pharmacol, 366, 226, 10.1007/s00210-002-0583-5 · doi:10.1007/s00210-002-0583-5
- Filip, 2006, Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats, Psychopharmacology (Berl), 183, 482, 10.1007/s00213-005-0197-y · doi:10.1007/s00213-005-0197-y
- Fletcher, 1999, RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors, Behav Pharmacol, 10, 183, 10.1097/00008877-199903000-00007 · doi:10.1097/00008877-199903000-00007
- Frankel, 2004, m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor, Behav Neurosci, 118, 157, 10.1037/0735-7044.118.1.157 · doi:10.1037/0735-7044.118.1.157
- George, 1997, Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects, Am J Psychiatry, 154, 81, 10.1176/ajp.154.1.81 · doi:10.1176/ajp.154.1.81
- Glennon, 2000, MDMA stimulus generalization to the 5-HT1A serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin, Pharmacol Biochem Behav, 66, 483, 10.1016/S0091-3057(00)00174-X · doi:10.1016/s0091-3057(00)00174-x
- Grauer, 1992, Morphine induces an increase in extracellular serotonin in the rat diencephalon, Brain Res, 599, 277, 10.1016/0006-8993(92)90402-U · doi:10.1016/0006-8993(92)90402-u
- Gulati, 1988, Cerebral cortical 5-Ht1 and 5-Ht2 receptors of morphine tolerant-dependent rats, Neuropharmacology, 27, 1231, 10.1016/0028-3908(88)90025-1 · doi:10.1016/0028-3908(88)90025-1
- Gulati, 1989, Brain and spinal-cord 5-Ht2 receptors of morphine-tolerant-dependent and morphine-abstinent rats, Eur J Pharmacol, 167, 185, 10.1016/0014-2999(89)90578-5 · doi:10.1016/0014-2999(89)90578-5
- Higgins, 1992, Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system, Neurosci Biobehav Rev, 16, 535, 10.1016/S0149-7634(05)80195-2 · doi:10.1016/s0149-7634(05)80195-2
- Higgins, 1993, Preliminary findings with the indirect 5-Ht agonist dexfenfluramine on heroin discrimination and self-administration in rats, Pharmacol Biochem Behav, 45, 963, 10.1016/0091-3057(93)90148-M · doi:10.1016/0091-3057(93)90148-m
- Ikeda, 2011, Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain, Eur J Pharmacol, 660, 318, 10.1016/j.ejphar.2011.03.050 · doi:10.1016/j.ejphar.2011.03.050
- Ivanova, 2002, Effect of monoamine oxidase A knockout on resistance to long-term exposure to ethanol, Bull Exp Biol Med, 133, 603, 10.1023/A:1020254430169 · doi:10.1023/a:1020254430169
- Javaid, 1993, Repeated cocaine administration does not affect 5-Ht receptor subtypes (5-Ht(1A), 5-Ht2) in several rat-brain regions, Eur J Pharmacol, 238, 425, 10.1016/0014-2999(93)90880-Q · doi:10.1016/0014-2999(93)90880-q
- Johnson, 1993, Effects of chronic cocaine administration on the serotonergic system in the rat-brain, Pharmacol Bioch Behav, 46, 289, 10.1016/0091-3057(93)90355-W · doi:10.1016/0091-3057(93)90355-w
- Kenna, 2010, Medications acting on the serotonergic system for the treatment of alcohol dependent patients, Curr Pharm Des, 16, 2126, 10.2174/138161210791516396 · doi:10.2174/138161210791516396
- King, 1993, Withdrawal from continuous or intermittent cocaine – effects of Nan-190 on cocaine-induced locomotion, Pharmacol Biochem Behav, 44, 253, 10.1016/0091-3057(93)90459-7 · doi:10.1016/0091-3057(93)90459-7
- King, 1994, 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine, Pharmacol Biochem Behav, 47, 399, 10.1016/0091-3057(94)90135-X · doi:10.1016/0091-3057(94)90135-x
- Koetzner, 1995, Facilitating role of m-chlorophenylbiguanide in a cocaine discrimination, Pharmacol Biochem Behav, 52, 815, 10.1016/0091-3057(95)00176-W · doi:10.1016/0091-3057(95)00176-w
- Kotler, 1999, No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (Ball D2DR) polymorphisms and heroin addiction, Mol Psychiatry, 4, 313, 10.1038/sj.mp.4000499 · doi:10.1038/sj.mp.4000499
- Lamb, 2014, Ethanol effects on multiple fixed-interval, fixed-ratio responding in mice with deletions of the serotonin transporter gene, Behav Pharmacol, 25, 92, 10.1097/FBP.0000000000000011 · doi:10.1097/fbp.0000000000000011
- Landabaso, 1998, A randomized trial of adding fluoxetine to a naltrexone treatment programm for heroin addicts, Addiction, 93, 739, 10.1046/j.1360-0443.1998.9357399.x · doi:10.1046/j.1360-0443.1998.9357399.x
- Lehmann, 2000, When injected into the fimbria-fornix/cingular bundle, not in the raphe, 5,7-dihydroxytryptamine prevents amphetamine-induced hyperlocomotion, Behav Brain Res, 114, 213, 10.1016/S0166-4328(00)00246-1 · doi:10.1016/s0166-4328(00)00246-1
- Li, 2011, Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys, Neuropsychopharmacology, 36, 940, 10.1038/npp.2010.232 · doi:10.1038/npp.2010.232
- Li, 2002, Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects, Am J Med Genet, 114, 329, 10.1002/ajmg.10200 · DOI
- Liu, 2006, Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity, Drug Alcohol Depend, 81, 275, 10.1016/j.drugalcdep.2005.07.007 · doi:10.1016/j.drugalcdep.2005.07.007
- Lovinger, 2000, Ethanol and trichloroethanol alter gating of 5-HT3 receptor-channels in NCB-20 neuroblastoma cells, Neuropharmacology, 39, 561, 10.1016/S0028-3908(99)00164-1 · doi:10.1016/s0028-3908(99)00164-1
- Lu, 1993, Ethanol consumption following acute fenfluramine, fluoxetine, and dietary tryptophan, Pharmacol Biochem Behav, 44, 931, 10.1016/0091-3057(93)90027-Q · doi:10.1016/0091-3057(93)90027-q
- Lu, 1994, Ethanol consumption following acute treatment with methysergide, fluoxetine, fenfluramine, and their combination, Alcohol Clin Exp Res, 18, 60, 10.1111/j.1530-0277.1994.tb00881.x · doi:10.1111/j.1530-0277.1994.tb00881.x
- Maurel, 1997, Substitution of the selective serotonin reuptake inhibitors fluoxetine and paroxetine for the discriminative stimulus effects of ethanol in rats, Psychopharmacology (Berl), 130, 404, 10.1007/s002130050257 · doi:10.1007/s002130050257
- Maurel, 1999, Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats, Alcohol, 17, 195, 10.1016/S0741-8329(98)00046-9 · doi:10.1016/s0741-8329(98)00046-9
- Maurel, 1999, 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats, Pharmacol Biochem Behav, 62, 89, 10.1016/S0091-3057(98)00115-4 · doi:10.1016/s0091-3057(98)00115-4
- McCorvy, 2011, A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference, Neurosci Lett, 505, 10, 10.1016/j.neulet.2011.07.036 · doi:10.1016/j.neulet.2011.07.036
- McMahon, 1999, Antagonism of 5-hydroxytryptamine(4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell, J Pharmacol Exp Ther, 291, 300, 10.1016/S0022-3565(24)35101-8 · DOI
- Millan, 1998, J Pharmacol Exp Ther, 286, 1356, 10.1016/S0022-3565(24)37732-8 · doi:10.1016/s0022-3565(24)37732-8
- Miranda, 2007, Modulatory role of 5-HT1B receptors in the discriminative signal of amphetamine in the conditioned taste aversion paradigm, Pharmacol Rep, 59, 517
- Molina, 2001, l-Tryptophan attenuation of the dopaminergic and behavioral responses to cocaine, Life Sci, 69, 1897, 10.1016/S0024-3205(01)01276-0 · doi:10.1016/s0024-3205(01)01276-0
- Moser, 1992, The effect of 5-HT3 receptor antagonists on the discriminative stimulus effects of amphetamine, Eur J Pharmacol, 212, 271, 10.1016/0014-2999(92)90342-2 · doi:10.1016/0014-2999(92)90342-2
- Müller, 2004, Nucleus accumbens serotonin1A receptors control cocaine-induced hyperactivity but not local serotonin increase: an in vivo microdialysis study, Neuropharmacology, 47, 205, 10.1016/j.neuropharm.2004.03.020 · DOI
- Munn, 2002, Increases in the release and metabolism of serotonin in nucleus parafascicularis thalami following systemically administered morphine in the rat, Neurosci Lett, 332, 151, 10.1016/S0304-3940(02)00949-7 · doi:10.1016/s0304-3940(02)00949-7
- Nader, 1994, Blockade of the discriminative stimulus effects of d-amphetamine in rhesus-monkeys with serotonin 5-Ht1A agonists, Behav Pharmacol, 5, 591, 10.1097/00008877-199410000-00004 · doi:10.1097/00008877-199410000-00004
- Nakamura, 2006, Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonst in mice, Synapse, 60, 479, 10.1002/syn.20323 · doi:10.1002/syn.20323
- Paris, 1991, Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine, Psychopharmacology (Berl), 104, 475, 10.1007/BF02245652 · doi:10.1007/bf02245652
- Platt, 1999, Discriminative stimulus effects of morphine in squirrel monkeys: Stimulants, opioids, and stimulant-opioid combinations, J Pharmacol Exp Ther, 290, 1092, 10.1016/S0022-3565(24)35010-4 · DOI
- Powell, 1994, Serotonin Involvement in the discriminative stimulus effects of mu-opioids and kappa-opioids in rats, Behav Pharmacol, 5, 255
- Przegalinski, 2002, Effects of 5-HT1B receptor ligands microinjected into the accumbal shell or core on the cocaine-induced locomotor hyperactivity in rats, J Physiol Pharmacol, 53, 383
- Przegalinski, 2003, Withdrawal from chronic cocaine up-regulates 5-HT1B receptors in the rat brain, Neurosci Lett, 351, 169, 10.1016/j.neulet.2003.08.007 · doi:10.1016/j.neulet.2003.08.007
- Przegalinski, 2004, Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats, Eur Neuropsychopharmacol, 14, 217, 10.1016/S0924-977X(03)00106-8 · doi:10.1016/s0924-977x(03)00106-8
- Pullagurla, 2004, Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245, Pharmacol Biochem Behav, 78, 263, 10.1016/j.pbb.2004.03.017 · doi:10.1016/j.pbb.2004.03.017
- Rapoza, 1993, Buspirone fails to affect the discriminative stimulus effects of cocaine, Pharmacol Biochem Behav, 45, 179, 10.1016/0091-3057(93)90102-Y · doi:10.1016/0091-3057(93)90102-y
- Reith, 1990, 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice, Eur J Pharmacol, 186, 327, 10.1016/0014-2999(90)90454-E · doi:10.1016/0014-2999(90)90454-e
- Rezvani, 1994, Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction, Pharmacol Biochem Behav, 48, 105, 10.1016/0091-3057(94)90505-3 · doi:10.1016/0091-3057(94)90505-3
- Rodd-Henricks, 2000, Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats, Alcohol, 21, 73, 10.1016/S0741-8329(00)00083-5 · doi:10.1016/s0741-8329(00)00083-5
- Rowland, 1992, Effect of dexfenfluramine on alcohol intake in alcohol-preferring “P” rats, Alcohol, 9, 559, 10.1016/0741-8329(92)90097-T · doi:10.1016/0741-8329(92)90097-t
- Roychoudhury, 1996, Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist, Meth Find Exp Clin Pharmacol, 18, 677
- Schechter, 1972, Nicotine as a discriminative stimulus in rats depleted of norepinephrine or 5-hydroxytryptamine, Psychopharmacologia, 24, 417, 10.1007/BF00402536 · doi:10.1007/bf00402536
- Sershen, 1996, Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum, Pharmacol Biochem Behav, 53, 863, 10.1016/0091-3057(95)02098-5 · doi:10.1016/0091-3057(95)02098-5
- Sills, 1997, Fluoxetine attenuated morphine-induced locomotion and blocks morphine-sensitization, Eur J Pharmacol, 337, 161, 10.1016/S0014-2999(97)01308-3 · doi:10.1016/s0014-2999(97)01308-3
- Soto, 2009, Citalopram enhances cocaine's subjective effects in rats, Behav Pharmacol, 20, 759, 10.1097/FBP.0b013e328333a267 · doi:10.1097/fbp.0b013e328333a267
- Spealman, 1993, Modification of behavioral-effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel-monkeys, Psychopharmacology, 112, 93, 10.1007/BF02247368 · doi:10.1007/bf02247368
- Sprouse, 1989, Mdma (3,4-Methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain-slices via release of serotonin, Eur J Pharmacol, 167, 375, 10.1016/0014-2999(89)90446-9 · doi:10.1016/0014-2999(89)90446-9
- Starr, 2012, Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus, J Pharmacol Exp Ther, 340, 73, 10.1124/jpet.111.185728 · doi:10.1124/jpet.111.185728
- Sudakov, 2007, Self-administration of morphine by rats causes monoamine release in the anterior cingulate cortex, Bull Exp Biol Med, 144, 210, 10.1007/s10517-007-0291-8 · doi:10.1007/s10517-007-0291-8
- Suzuki, 1992, 5-HT3 receptor antagonists block cocaine- and methamphetamine-induced place preference, Yakubutsu Seishin Kodo, 12, 33
- Tristan-Noguero, 2013, Lack of association between the LPR and VNTR polymorphisms of the serotonin transporter gene and cocaine dependence in a Spanish sample, Psychiatry Res, 210, 1287, 10.1016/j.psychres.2013.09.004 · doi:10.1016/j.psychres.2013.09.004
- Wang, 1995, Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration, Psychopharmacology, 120, 134, 10.1007/BF02246185 · doi:10.1007/bf02246185
- Wilson, 1996, The 5-HT1A receptor agonist 8-OH-DPAT reduces ethanol intake and maintained behavior in female Sprague-Dawley rats, Alcohol, 13, 407, 10.1016/0741-8329(95)02110-8 · doi:10.1016/0741-8329(95)02110-8
- Winter, 1977, Morphine and ethanol as discriminative stimuli – absence of antagonism by para-chlorophenylalanine methyl-ester, cinanserin, or Bc-105, Psychopharmacology, 53, 159, 10.1007/BF00426486 · doi:10.1007/bf00426486
- Wrzosek, 2012, Serotonin 2A receptor gene (HTR2A) polymorphism in alcohol-dependent patients, Pharmacol Rep, 64, 449, 10.1016/S1734-1140(12)70787-9 · doi:10.1016/s1734-1140(12)70787-9
- Yeh, 1991, Cocaine-induced locomotor-activity in rats, Pharmacol Biochem Behav, 39, 723, 10.1016/0091-3057(91)90154-T · doi:10.1016/0091-3057(91)90154-t
- Young, 2006, Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT), Pharmacol Biochem Behav, 83, 612, 10.1016/j.pbb.2006.03.025 · doi:10.1016/j.pbb.2006.03.025
- Yubero-Lahoz, 2012, Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain, Eur J Pharmacol, 674, 337, 10.1016/j.ejphar.2011.10.033 · doi:10.1016/j.ejphar.2011.10.033
- Zhou, 1994, Reduced serotonergic immunoreactive fibers in the forebrain of alcohol-preferring rats, Alcohol Clin Exp Res, 18, 571, 10.1111/j.1530-0277.1994.tb00912.x · DOI
Cited by
The Roles of Serotonin in Neuropsychiatric Disorders
Pourhamzeh, M., Moravej, F. G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R., Ahadi, R., & Joghataei, M. T. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01064-9 · Cited by 366
Adolescent Alcohol Exposure Persistently Impacts Adult Neurobiology and Behavior
Crews, F. T., Vetreno, R. P., Broadwater, M. A., & Robinson, D. L. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012138 · Cited by 324
Neuroscience of Addiction: Relevance to Prevention and Treatment
Volkow, N. D., & Boyle, M. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101174 · Cited by 322
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Lipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Self-citation
Metadata
- Authors
- Müller, C. P., & Homberg, J. R.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 277
- Pages
- 146-192
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2080867289
- Cited by
- 334
- References
- 706
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Friedrich-Alexander-University of Erlangen-Nuremberg
- Dutch Organisation for Scientific Research (40-00812-98-11002, 60-60600-97-354)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.